Funding for this research was provided by:
World Federation of Neurology (Grant in Aid)
Received: 9 June 2020
Accepted: 26 October 2020
First Online: 3 November 2020
Ethics approval and consent to participate
: Ethics approvals were granted by the Institutional Review Board of Columbia University Irving Medical Center (New York, New York, United States) and Ethics Committees of University of Malawi College of Medicine (Blantyre, Malawi) and University of the Western Cape (Bellville, South Africa). All participants were consented before participating in the study. All participants received information about the purposes and procedures of the study in written and verbal form. For caregivers, recruiters explained that participation would not impact the care of their child; for healthcare workers, recruiters explained that participation would not affect their employment. Caregivers were consented on the PRW before their child’s discharge once CM was no longer acute. Participants who could not complete the written consent provided verbal consent.
: Not applicable.
: Gretchen Birbeck has active NIH funding for research projects relevant to epilepsy, HIV, and malaria. She is on the Board of Directors for the American Neurological Association and the Advisory Board for the US NIH’s Fogarty International Center. She also serves on the Tafenoquine Advisory Board for GlaxoSmithKline. All other authors have no competing interests.